Astaxanthin

产品说明书

Print
Chemical Structure| 472-61-7 同义名 : -
CAS号 : 472-61-7
货号 : A186372
分子式 : C40H52O4
纯度 : 95%
分子量 : 596.84
MDL号 : MFCD00672621
存储条件:

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:

IP 2% DMSO+2% Tween80+30% PEG300+water 0.4 mg/mL clear

PO 0.5% CMC-Na 22 mg/mL suspension

生物活性
描述 Astaxanthin is a xanthophyll carotenoid which is found in various microorganisms and marine animals. Astaxanthin reduced the DNA oxidative damage biomarker inflammation and astaxanthin showed protective effect on high glucose induced oxidative stress, inflammation and apoptosis in proximal tubular epithelial cells[3].The serum adiponectin level was also increased by astaxanthin (12 or 18 mg/day), and the changes of adiponectin positively correlated with the high-density lipoprotein (HDL)-cholesterol changes[4].
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT02264938 Macular Degeneration Not Applicable Completed - -
NCT03702374 Diabetic Retinopathy Phase 3 Recruiting November 1, 2020 Mexico ... 展开 >> Institute of Experimental and Clinical Therapeutics, Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Adolfo D. Rodriguez-Carrizalez, PhD    +52 33 10585200 ext 33658    adolfo.rodriguez@academicos.udg.mx    Contact: Cecilia Olvera-Montaño, MD    +52 33 10 58 52 00 ext 33658    ceciliaom.drcrt@gmail.com    Sub-Investigator: Cecilia Olvera-Montaño, MD          Sub-Investigator: José A. Castellanos-González, MSc          Sub-Investigator: Alejandra G Miranda-Díaz, PhD 收起 <<
NCT02582424 Hyperlipidemia Not Applicable Completed - -
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.68mL

0.34mL

0.17mL

8.38mL

1.68mL

0.84mL

16.75mL

3.35mL

1.68mL

参考文献

[1]Zheng D, Li Y, et al. The protective effect of astaxanthin on fetal alcohol spectrum disorder in mice. Neuropharmacology. 2014 Sep;84:13-8.

[2]Chen WP, Xiong Y, et al. Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes. Int Immunopharmacol. 2014 Mar;19(1):174-7.

[3]Ambati RR, Phang SM, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review. Mar Drugs. 2014 Jan 7;12(1):128-52. doi: 10.3390/md12010128. PMID: 24402174; PMCID: PMC3917265.

[4]Kishimoto Y, Yoshida H, Kondo K. Potential Anti-Atherosclerotic Properties of Astaxanthin. Mar Drugs. 2016 Feb 5;14(2):35. doi: 10.3390/md14020035. PMID: 26861359; PMCID: PMC4771988.